Anzeige
Mehr »
Login
Dienstag, 15.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Diese Fusion könnte der Katalysator sein, den Anleger brauchen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Medien-Archiv vom 02.04.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
02.04.Kiniksa Pharmaceuticals, Ltd.: Kiniksa Pharmaceuticals Announces Development Indication for Abiprubart61- Abiprubart Phase 2b trial in Sjogren's Disease planned to initiate in 2H 2024 -- Abiprubart Phase 2 Cohort 4 rheumatoid arthritis data further validate biological activity -- Abiprubart development...
► Artikel lesen
02.04.UL Solutions Announces Launch of Initial Public Offering70NORTHBROOK, Ill.--(BUSINESS WIRE)--UL Solutions Inc. ("UL Solutions") today announced the launch of its initial public offering (the "IPO") of 28,000,000 shares of its Class A common stock and...
► Artikel lesen
02.04.MediaValet Inc. Acquired by Affiliate of STG114VANCOUVER, BC, April 2, 2024 /CNW/ - MediaValet Inc. (TSX: MVP) ("MV" or the "Company"), a leading provider of enterprise digital asset management (DAM), video content management and creative operations...
► Artikel lesen
02.04.Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Announce Business Combination to Form Traws Pharma, Inc, a Best-in-Class Virology and Oncology Company132Closing cash balance of approximately $28 million expected from concurrent private placement led by OrbiMed and Torrey PinesFunding expected to advance development of three potential best-in-class/class...
► Artikel lesen
02.04.FibroGen, Inc.: FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer149FG-3246 demonstrated efficacy in adenocarcinoma selected cohorts receiving biologically active doses of FG-3246 at = 1.2 mg/kg in heavily pre-treated, biomarker unselected patients: Median radiographic...
► Artikel lesen
02.04.Sow Good Inc.: Sow Good Appoints Brendon Fischer as Interim Chief Financial Officer67IRVING, Texas, April 02, 2024 (GLOBE NEWSWIRE) -- Sow Good Inc. (OTCQB: SOWG) ("Sow Good" or "the Company"), a trailblazer in the freeze dried candy and treat industry, announced today that Brendon...
► Artikel lesen
02.04.Fluent, Inc.: Fluent Announces Fourth Quarter and Full-Year 2023 Financial Results180Revenue of $72.8 million for Q4 2023 and $298.4 million for FY 2023Net loss of $1.9 million for Q4 2023 and $63.2 million for FY 2023Gross profit (exclusive of depreciation and amortization) of $20.8...
► Artikel lesen
02.04.Intermap Technologies: Intermap Announces 2023 Results and 2024 Guidance107Software and solutions revenue grew 25% in 2023 Company projects 2024 bookings of $20 - 25 million, revenue of $16 - 18 million and an adjusted EBITDA margin of approximately 25% DENVER, April 02...
► Artikel lesen
02.04.Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)145BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
► Artikel lesen
02.04.D-BOX Technologies Inc.: Joshua Chandler joins D-BOX as the new Chief Financial Officer108MONTREAL, April 02, 2024 (GLOBE NEWSWIRE) -- D-BOX Technologies Inc. ("D-BOX" or the "Corporation") (TSX:DBO), a world leader in haptic and immersive entertainment, is pleased to announce the appointment...
► Artikel lesen
02.04.African Rainbow Minerals Limited Acquires Shares of Surge Copper Corp.282TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- African Rainbow Minerals Limited (JSE: ARI) (A2X: ARI) ("ARM") announces that it has agreed to subscribe for, through its wholly-owned subsidiary ARM Copper...
► Artikel lesen
02.04.Centogene NV: CENTOGENE Receives Nasdaq Non-Compliance Notice315CAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, April 02, 2024 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG) ("Centogene", "we", or the "Company"), the essential life science partner for data-driven...
► Artikel lesen
02.04.Edible Garden AG Incorporated: Edible Garden Announces Reverse Stock Split of the Company's Common Stock111BELVIDERE, NJ, April 02, 2024 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (Nasdaq: EDBL, EDBLW), a leader in controlled environment agriculture (CEA), locally...
► Artikel lesen
02.04.Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)125SAN FRANCISCO, April 02, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. ("Olema" or "Olema Oncology", Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development...
► Artikel lesen
02.04.Microchip Technology Inc.: Microchip Technology Appoints Rich Simoncic as Chief Operating Officer193CHANDLER, Ariz., April 02, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: MCHP) - Microchip Technology Incorporated, a leading provider of smart, connected and secure embedded control solutions, today announced...
► Artikel lesen
02.04.Nanobiotix S.A.: Nanobiotix Announces Completion of Phase 1 Dose Escalation and NBTXR3 Recommended Phase 2 Dose for the Treatment of Inoperable, Recurrent Lung Cancer in Patients Amenable to Re-Irradiation104Established recommended Phase 2 dose of NBTXR3 for the treatment of patients with inoperable, recurrent non-small cell lung cancer ("NSCLC") who have previously received definitive radiation therapyConfirmation...
► Artikel lesen
02.04.Locafy Limited: Locafy Reports Fiscal First Half 2024 Results200Fiscal First Half 2024 Highlighted by Ongoing Cost Reduction Initiatives Resulting in $3.6 Million Year-Over-Year Decrease in Operating Expenses Partnerships with diDNA and Localista, Hotfrog Proximity...
► Artikel lesen
02.04.View, Inc. Reaches Agreement with Cantor Fitzgerald and RXR to Become a Private Company185Balance sheet restructuring designed to strengthen View's financial position Approvals received from key stakeholders across capital structure MILPITAS, Calif., April 02, 2024 (GLOBE NEWSWIRE) --...
► Artikel lesen
02.04.X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)111BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that, effective...
► Artikel lesen
02.04.Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue164SEATTLE, April 02, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune...
► Artikel lesen
Seite:  Weiter >>